Dr. Jaehyun Jeon Consultant Infectious Diseases

Awards & Achievements

• 2015 Staff of the year in SKSH
• 2022 Ministry of Health and Welfare Award for COVID-19 response
• 2025 Nominated candidates for Korean Federation of Science and Technology Society (KOFST) Award

Research & Publications

• Clinical presentation, viral shedding, and neutralizing antibody responses of mpox cases in South Korea: single-center experience. Journal of Clinical Virology. 2024 Aug 1;173:105692.
• Severe mpox requiring colostomy in a patient with advanced HIV disease: a case report and literature review. Journal of Infection and Chemotherapy. 2024 Jun 25.
• Genomic analysis of monkeypox virus during the 2023 epidemic in Korea. Journal of Korean Medical Science. 2024 May 5;39(18).
• Magnitude and duration of serum neutralizing antibody titers induced by a third mRNA COVID-19 vaccination against Omicron BA.1 in older individuals. Infection & Chemotherapy. 2024 Mar;56(1):25.
• Adverse reactions after intradermal vaccination with JYNNEOS for mpox in Korea. Journal of Korean Medical Science. 2024 Mar 3;39(8).
• Propensity score-matched analysis for the safety and effectiveness of remdesivir in COVID-19 patients with renal impairment. BMC Infectious Diseases. 2024 Jan 2;24(1):3.
• Changes in the intrinsic severity of severe acute respiratory syndrome coronavirus 2 according to emerging variants: a nationwide study from February 2020 to June 2022, including comparison with vaccinated populations. BMC Infectious Diseases. 2024 Jan 2;24(1):1.
• Clinical features of mpox patients in Korea: a multicenter retrospective study. Journal of Korean Medical Science. 2024 Jan 1;39(4).
• Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant periods in Korea: using K-COV-N cohort in the National Health Insurance Service. PLoS ONE 19(3): e0300306. https://doi.org/10.1371/journal.pone.0300306
• Changes in the intrinsic severity of severe acute respiratory syndrome coronavirus 2 according to emerging variants: a nationwide study from February 2020 to June 2022, including comparison with vaccinated populations. BMC Infect Dis 24, 1 (2024).
• https://doi.org/10.1186/s12879-023-08869-7 Possibility of decreasing incidence of human immunodeficiency virus infection in Korea. Infection & Chemotherapy. 2023 Dec;55(4):451.
• A case of human mpox with isolated perianal ulcer development in the convalescent phase. Infection & Chemotherapy. 2023 Mar;55(1):128.
• Real-world effectiveness of nirmatrelvir-ritonavir and its acceptability in high-risk COVID-19 patients. Journal of Korean Medical Science. 2023 Sep 4;38(35).
• Short-term effectiveness of oral nirmatrelvir/ritonavir against the SARS-CoV-2 Omicron variant and culture-positive viral shedding. JKMS, original article, 2023-02. https://doi.org/10.3346/jkms.2023.38.e59
• Treatment options for patients with mild-to-moderate coronavirus disease 2019 in Korea. JKMS, review, 2022-12. https://doi.org/10.3346/jkms.2022.37.e352
• Prognostic factors for pulmonary fibrosis following pneumonia in patients with COVID-19: a prospective study. Journal of Clinical Medicine, original article, 2022-10. https://doi.org/10.3390/jcm11195913
• The association between greenness exposure and COVID-19 incidence in South Korea: an ecological study. Science of The Total Environment, original article, 2022-08. https://doi.org/10.1016/j.scitotenv.2022.154981
• Suicide attempt-related emergency department visits among adolescents: a nationwide population-based study in Korea, 2016–2019. BMC Psychiatry, original article, 2022-06. https://doi.org/10.1186/s12888-022-04043-6
• Booster BNT162b2 COVID-19 vaccination increases neutralizing antibody titers against the SARS-CoV-2 Omicron variant in both young and elderly adults. JKMS, original article, 2022-02. https://doi.org/10.3346/jkms.2022.37.e70
• Clinical characteristics of 40 patients infected with the SARS-CoV-2 Omicron variant in Korea. JKMS, original article, 2022-01. https://doi.org/10.3346/jkms.2022.37.e352
• The use of personal protective equipment among frontline nurses in a nationally designated COVID-19 hospital. Infection and Chemotherapy, original article, 2021-12. [DOI missing]
• Risk factors for the delayed diagnosis of extrapulmonary TB. International Journal of Tuberculous Lung Disease, original article, 2021-03. https://doi.org/10.5588/ijtld.20.0788
• Incidence and seasonality of respiratory viruses causing acute respiratory infections in the northern United Arab Emirates. J Med Virol., original article, 2019-8. 10.4103/abhs.abhs_16_22
• Impact of antimicrobial treatment duration on outcome of Staphylococcus aureus bacteremia: a cohort study. Clin Microbiol Infect., original article, 2019-6. https://doi.org/10.1016/j.cmi.2018.09.018
• The effect of incorporating simultaneous covert observation and overt observation into established hand hygiene promotion programs. Am J Infect Control., original article, 2019-5. https://doi.org/10.1016/j.ajic.2018.11.002
• Population pharmacokinetic analysis of meropenem after intravenous infusion in Korean patients with acute infections. Clin Ther., original article, 2018-8. https://doi.org/10.3390/pharmaceutics13111861
• Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease. Eur J Clin Microbiol Infect Dis., original article, 2018-5.

Education & Training

• Bachelor of Medicine, Kyungpook National University, College of Medicine, Daegu, Korea, 1999
• Master of Medical Immunology, Kyungpook National University, College of Medicine, Daegu, Korea, 2010
• Doctor of Philosophy in Microbiology, Kyungpook National University, College of Medicine, Daegu, Korea, 2023

Expertise

• 22 years as an Internal Medicine Consultant (Diagnosis, Treatment, and Prevention of internal medical issues)
• 16 years as an Infectious Disease Consultant (Diagnosis, Treatment, and Prevention of infectious diseases, including emerging and re-emerging diseases)
• 16 years in HIV management
• 16 years in Infection Control and Antibiotic Stewardship
• 15 years specializing in Bone and Joint Infection
• 10 years in Travel Medicine
• 10 years as Ultrasound-Guided Vascular Access Team Leader
• 15 years of Critical Care experience with invasive procedures (PICC, ECMO, central catheter insertion, bedside ultrasound, chest tube, PCD, invasive airway management) and nutrition
• 9 years in Hematologic and Oncologic Infection, including transplantation infection
• Response to transmissible diseases
• Medical student education
• Infectious disease education
• Residency education, including invasive procedures

Membership

• 2024–Present: Certified Member (CTH), International Society of Travel Medicine
• 2021–Present: Member, Executive Committee of GFID (Government-wide R&D Fund for Infectious Disease Research)
• 2021–Present: WHO Accredited Korea Disaster Relief Team
• 2014–Present: Certified Member, Korean Society of Critical Care Medicine
• 2010–Present: Member, Korean Society of Infectious Disease
• Member, Korean Society of HIV/AIDS

Professional Journey

• Professor, Consultant, Kyung-Hee University Hospital, Seoul, Korea January 1, 2025 – Present Consultant of Infectious Disease Consultant of Internal Medicine Intensivist, Chief of Medical Intensive Care Unit
• Consultant, Veterans Healthcare System, Central Hospital, Seoul, Korea April 1, 2024 – September 30, 2024 Consultant of Infectious Disease Consultant of Internal Medicine Hospitalist
• Consultant, National Medical Center, Seoul, Korea July 15, 2020 – March 15, 2024 Chief of High-level Infectious Disease Isolation Unit and Infectious Disease Specialty Critical Care Unit Chief of Infectious Disease Research Center Director of HIV Clinic and Travel Clinic Director of Infection Prevention and Control Team Consultant of Infectious Disease Consultant of Internal Medicine Accreditation Preparation Member of Korean Disaster Relief Team (KDRT) (WHO accredited) Fellowship in Critical Care (renewal)
• Professor, Consultant, Ewha Women’s University, Seoul, Korea January 1, 2020 – July 14, 2020 Consultant of Infectious Disease Consultant of Internal Medicine Consultant of Critical Care
• Consultant, Veterans’ Health Service, Seoul, Korea January 4, 2019 – December 31, 2019 Director of Infectious Disease Division Consultant of Infectious Disease Consultant of Internal Medicine
• Clinical Associate Professor, Seoul National University, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, UAE November 25, 2014 – December 24, 2018 Founding Member of SKSH Consultant of Infectious Disease Consultant of Critical Care Chief of Infection Prevention and Control Team Leader of Preparation Team for Joint Commission International Accreditation
• Assistant Professor, Inje University Haeundae Hospital, Busan, Korea September 1, 2012 – September 30, 2014 Consultant of Internal Medicine Consultant of Infectious Disease Teaching Professor of Medical College Fellowship in Critical Care
• Consultant of Infectious Disease, Dongnam Institution of Radiology and Medical Science, Busan, Korea March 1, 2010 – August 31, 2012 Director of Department of Internal Medicine Chief of Infection Control, Prevention, and Quality Improvement Team Division Head of Infectious Disease Critical Care Physician
• Assistant Professor, Seoul National University Hospital Gangnam Center, Seoul, Korea March 1, 2009 – February 28, 2010 Chief of Infection Control and Prevention Consultant of Infectious Disease Sexually Transmitted Disease Clinic and Vaccine Clinic Travel Medicine Physician, Health Promotion Center
• Assistant Professor, Seoul National University Bundang Hospital, Bundang, Gyeonggi, Korea March 1, 2008 – February 28, 2009 Consultant of Infectious Disease Deputy Chief of Infection Control and Prevention Travel Medicine Physician, Health Promotion Center
• Specialist of Internal Medicine, Army Service, Daegu, Korea May 1, 2004 – April 30, 2007 Consultant of Internal Medicine

Fellowship

• Fellowship, Seoul National University Hospital, Seoul, Korea March 1, 2007 – February 28, 2008 Fellowship in Infectious Disease Consultant of Internal Medicine